TBPH
NASDAQ · Pharmaceuticals
Theravance Biopharma Inc
$16.58
-0.13 (-0.78%)
Open$16.72
Previous Close$16.71
Day High$16.85
Day Low$16.48
52W High$21.03
52W Low$10.44
Volume—
Avg Volume372.7K
Market Cap854.75M
P/E Ratio7.46
EPS$2.20
SectorPharmaceuticals
Analyst Ratings
Buy
12 analysts
Price Target
+50.5% upside
Current
$16.58
$16.58
Target
$24.95
$24.95
$16.23
$24.95 avg
$30.59
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 106.72M | 83.41M | 591.55M |
| Net Income | 105.16M | 73.97M | 75.68M |
| Profit Margin | 98.5% | 93.6% | 12.8% |
| EBITDA | 47.69M | 35.41M | 125.32M |
| Free Cash Flow | — | — | 94.80M |
| Rev Growth | +28.0% | +28.0% | +8.8% |
| Debt/Equity | 0.11 | 0.11 | 1.02 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |